B

바이오스마트

038460KOSDAQ

58.0 / 100

Reference Date: 2026-09-08

Financial Score31.5 / 40
News Sentiment12.5 / 25
Momentum4.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Revenue metrics are weak. Declined 6.7% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

BioSmart operates diverse business segments including smart card manufacturing, pharmaceuticals, alcohol payment solutions, heavy electrical equipment, and publishing, leveraging cross-industry synergies for sustainable growth. The heavy electrical/electrical products segment contributes the highest revenue share, followed by smart card and pharmaceutical businesses.

Number of Employees

168people

Average Salary

57.0M KRW

Score Calculation Basis

Detailed Financial Score

PER
7.47Industry Average 15.008.0Point

Half of industry avg (excellent)

PBR
0.36Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE
5.22Industry Average 8.002.5Point

Below industry avg

Debt Ratio
17.05Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20256.0 / 10 points
Revenue Growth Rate
1.0 / 3

Avg ▲2.9% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲56.1% (2-year basis)

ROE Trend
2.0 / 4

Avg ROE 7.0% (declining, 3yr)

Detailed News Sentiment

2 totalPositive 0Neutral 2Negative 0Average Sentiment Score 50

Detailed Momentum

52-week position1.0Point

Near 52w low (8%, downtrend)

Current 2,660Won52-week high 6,25052-week low 2,325
1-month return2.0Point

1m -6.67% (slight drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0
  • Neutral반기보고서 (2026.06)2026-08-14
  • Neutral주식등의대량보유상황보고서(일반)2026-08-12